tm logo

Monitor this mark

View On USPTO

TREMFYA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 13 Nov 2023

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson Plaza

New Brunswick

NJ

08933

Serial Number

86799255 filed on 26th Oct 2015

Registration Number

5297001 registered on 26th Sep 2017

in the Principal Register

Correspondent Address

Cheryl L. Foytlin

Cheryl L. Foytlin

ONE JOHNSON & JOHNSON PLAZA

NEW BRUNSWICK NJ 08933

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

TREMFYA

Human pharmaceutical preparations for the treatment of auto-immune, inflammatory and dermatologic diseases

Classification Information

Class [005]
Pharmaceutical Products

Human pharmaceutical preparations for the treatment of auto-immune, inflammatory and dermatologic diseases

First Use Date in General

17th Jul 2017

First Use Date in Commerce

17th Jul 2017

Mark Details

Serial Number

No 86799255

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T40191US1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
13th Nov 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Nov 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
13th Nov 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
15th May 2023TEAS SECTION 8 & 15 RECEIVED
26th Sep 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
26th Sep 2017REGISTERED-PRINCIPAL REGISTER
19th Aug 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
18th Aug 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
14th Aug 2017STATEMENT OF USE PROCESSING COMPLETE
11th Aug 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL